This segment focuses on the research, development, and commercialization of pharmaceutical products targeting gastrointestinal disorders. Joincare leverages its expertise in drug formulation and delivery to create effective treatments for conditions such as ulcers, gastritis, and other digestive ailments. Research and development activities include clinical trials and formulation improvements. The company utilizes advanced technologies in drug delivery systems to enhance efficacy and patient compliance. The patient impact is significant, as these medications improve the quality of life for individuals suffering from chronic digestive issues. Joincare's market positioning is strong in China, with a focus on providing affordable and accessible healthcare solutions. Future opportunities include expanding the product portfolio and exploring new therapeutic areas within gastroenterology. Regulatory aspects involve obtaining approvals from relevant health authorities. Partnerships with research institutions and healthcare providers are crucial for clinical trials and market access.

This segment encompasses the development, manufacturing, and distribution of drugs for respiratory illnesses and infectious diseases. Joincare's R&D efforts focus on creating innovative therapies for conditions like influenza and other respiratory infections. The company utilizes advanced technologies in drug discovery and formulation to develop effective treatments. This segment addresses significant patient needs by providing medications that alleviate symptoms, prevent complications, and improve patient outcomes. Joincare's market position is strengthened by its partnerships and collaborations, including licensing agreements with global pharmaceutical companies. Future growth opportunities include expanding the product pipeline and entering new markets. Regulatory compliance is a key aspect, requiring adherence to stringent guidelines for drug development and approval. Clinical trials are essential for demonstrating the safety and efficacy of new drugs, and partnerships with healthcare providers are crucial for conducting these trials and ensuring market access.

This segment focuses on the research, development, and commercialization of healthcare products and supplements, including the Eagle brand health products. Joincare's R&D activities include the development of new formulations and the improvement of existing products, such as American ginseng tea, ginseng lozenges, and capsules. The company utilizes advanced manufacturing processes to ensure product quality and consistency. This segment addresses the growing demand for health and wellness products, improving the overall health and well-being of consumers. Joincare's market positioning is strong in China, with a focus on providing high-quality, natural health products. Future opportunities include expanding the product line and entering new markets. Regulatory compliance is a key aspect, requiring adherence to stringent guidelines for product safety and labeling. Partnerships with retailers and distributors are crucial for market access and sales.